Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ZTS	ZOETIS INC	$30.70B	69.30%	17.20%	26.97%	21.60%	3.79	3.08	71.50%	27.50%	36.88%
LUNG	PULMONX CORP	$75.59M	-96.70%	-38.30%	-46.38%	-47.10%	1.93	4.32	77.10%	-55.00%	-50.03%
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$1.91B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
SLGL	SOL-GEL TECHNOLOGIES LTD	$223.61M	-44.10%	-37.00%	-33.46%	-58.10%	0.12	10.37	100.00%	-968.40%	-968.41%
NAGE	NIAGEN BIOSCIENCE INC	$204.15M	20.50%	15.00%	18.60%	88.80%	0.29	6.50	64.20%	12.40%	13.19%
SI	SHOULDER INNOVATIONS INC	$376.20M	-25.70%	-21.20%	-26.34%	-26.80%	0.22	10.71	77.30%	-58.30%	-61.04%
PRVA	PRIVIA HEALTH GROUP INC	$2.77B	3.80%	2.00%	5.90%	-197.30%	0.83	1.62	10.00%	1.20%	2.14%
PEN	PENUMBRA INC	$12.61B	11.10%	8.60%	11.71%	13.90%	0.29	5.75	67.80%	10.70%	13.54%
STIM	NEURONETICS INC	$151.63M	-150.60%	-22.40%	-20.85%	-17.10%	6.16	1.88	49.10%	-19.60%	-13.87%
AGL	AGILON HEALTH INC	$1.44B	-110.30%	-15.60%	-80.50%	-529.80%	5.99	1.08	0.20%	-3.90%	-3.79%
PYPD	POLYPID LTD	$99.12M	-243.60%	-119.00%	-366.05%	-332.50%	1.83	1.35	N/A	N/A	N/A
RGNX	REGENXBIO INC	$479.26M	-220.10%	-46.00%	-50.82%	-28.30%	4.39	2.86	86.40%	-112.60%	-88.54%
INVA	INNOVIVA INC	$1.50B	30.00%	21.60%	26.43%	39.20%	0.38	16.01	72.20%	81.20%	99.46%
UTHR	UNITED THERAPEUTICS CORP	$23.31B	20.20%	18.00%	23.97%	31.10%	0.13	5.73	86.10%	41.60%	50.25%
MMED	MINIMED GROUP INC	$5.18B	N/A	N/A	N/A	N/A	0.30	1.81	N/A	N/A	N/A
TLPH	TALPHERA INC	$55.54M	-87.30%	-51.40%	-66.65%	-52.80%	0.86	4.30	100.00%	-1,507,600.00%	-1,507,600.00%
ELOX	ELOXX PHARMACEUTICALS INC	$51.26M	N/A	N/A	N/A	N/A	0.37	3.74	N/A	N/A	N/A
QUCY	QUANTUM CYBER NV	$94.16M	-209.40%	-144.50%	-116.80%	-10,163.70%	0.15	5.56	80.00%	-9,572.10%	-9,499.96%
DOCS	DOXIMITY INC	$5.45B	17.00%	14.50%	24.23%	31.70%	0.18	6.08	88.10%	25.50%	34.51%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$1.47B	N/A	-44.40%	-63.77%	-35.30%	-5.20	1.73	83.10%	-81.70%	-81.18%
SRPT	SAREPTA THERAPEUTICS INC	$1.74B	-10.00%	-4.10%	-4.87%	-4.30%	1.09	4.42	59.10%	-6.90%	-6.63%
OM	OUTSET MEDICAL INC	$76.32M	-62.30%	-28.80%	-30.04%	-21.10%	1.52	5.19	41.80%	-63.10%	-50.62%
BTMD	BIOTE CORP	$37.36M	-9.30%	5.70%	25.69%	12.80%	-2.43	1.43	68.60%	3.20%	10.02%
KZIA	KAZIA THERAPEUTICS LTD	$455.71M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
AXSM	AXSOME THERAPEUTICS INC	$8.19B	-255.60%	-27.00%	-61.82%	-127.70%	8.14	1.43	93.20%	-24.70%	-23.96%
XFOR	X4 PHARMACEUTICALS INC	$257.78M	-63.10%	-36.90%	-34.84%	-84.60%	0.63	11.30	81.50%	-568.80%	-513.82%
ZYME	ZYMEWORKS INC	$1.78B	-72.10%	-37.10%	-40.81%	-39.70%	3.94	6.32	100.00%	-404.00%	-384.43%
EDIT	EDITAS MEDICINE INC	$375.50M	-196.60%	-38.20%	-44.97%	-126.80%	1.26	3.19	100.00%	-157.30%	-161.60%
YDES	YD BIO LTD	$432.14M	6.40%	3.80%	3.40%	10.90%	1.25	5.23	29.60%	24.70%	24.67%
KYMR	KYMERA THERAPEUTICS INC	$8.87B	-21.50%	-19.50%	-19.01%	-22.00%	0.09	10.34	100.00%	-285.30%	-285.02%
ALGS	ALIGOS THERAPEUTICS INC	$68.82M	-160.70%	-92.30%	-199.07%	-228.40%	1.08	2.19	100.00%	-241.00%	-239.91%
IVA	INVENTIVA SA	$554.59M	N/A	-192.20%	-79.70%	-87.70%	-9.75	3.16	100.00%	-4,468.10%	-1,730.94%
BDX	BECTON DICKINSON & CO	$51.04B	3.80%	1.80%	4.20%	6.60%	1.08	0.87	46.40%	4.50%	8.33%
FATE	FATE THERAPEUTICS INC	$239.64M	-65.10%	-41.70%	-55.38%	-42.40%	0.70	4.85	100.00%	-1,941.10%	-1,941.09%
MRNA	MODERNA INC	$86.33B	-39.20%	-26.90%	-36.63%	-34.90%	0.62	2.30	23.40%	-141.40%	-138.55%
IFRX	INFLARX NV	$228.42M	-58.00%	-46.60%	-26.62%	-170.10%	0.14	8.22	48,201.60%	387,532.10%	386,807.32%
ADCT	ADC THERAPEUTICS SA	$217.04M	N/A	-32.70%	-23.34%	-43.10%	-2.22	3.03	88.90%	-121.80%	-56.61%
TEM	TEMPUS AI INC	$12.31B	-54.70%	-11.20%	-10.36%	-11.10%	4.32	3.30	64.00%	-17.80%	-14.29%
ATRA	ATARA BIOTHERAPEUTICS INC	$93.40M	N/A	-73.00%	-97.59%	-24.10%	-1.57	1.98	91.40%	-269.40%	-223.36%
APYX	APYX MEDICAL CORP	$109.52M	-78.70%	-13.90%	-5.05%	-4.20%	4.69	5.68	63.50%	-14.80%	-4.47%
FHTX	FOGHORN THERAPEUTICS INC	$109.86M	N/A	-31.20%	-42.26%	-68.00%	-3.51	3.36	100.00%	-175.80%	-175.78%
ASMB	ASSEMBLY BIOSCIENCES INC	$414.13M	0.00%	0.00%	-0.01%	0.00%	0.08	13.99	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$342.01M	-45.50%	-30.90%	-32.55%	-36.20%	0.45	5.45	100.00%	-289.40%	-289.09%
ALEC	ALECTOR INC	$208.80M	-531.00%	-44.00%	-69.72%	-67.00%	-21.35	5.26	100.00%	-850.10%	-847.98%
CTEV	CLARITEV CORP	$401.99M	N/A	-5.80%	0.68%	0.60%	-17.15	1.00	73.00%	-28.50%	3.10%
PHAT	PHATHOM PHARMACEUTICALS INC	$566.31M	N/A	-35.00%	-20.57%	-6.70%	-1.95	1.92	82.90%	-41.30%	-14.87%
TXG	10X GENOMICS INC	$9.35B	-9.30%	-7.30%	-8.22%	-17.20%	0.25	5.69	70.00%	-12.20%	-12.14%
CBLL	CERIBELL INC	$1.00B	-44.90%	-35.70%	-43.03%	-41.60%	0.30	9.18	88.90%	-64.70%	-62.95%
CBIO	CRESCENT BIOPHARMA INC	$479.53M	-99.10%	-86.90%	-99.33%	2,179.90%	0.12	9.66	100.00%	-1,522.70%	-1,504.28%
CRMD	CORMEDIX INC	$576.01M	44.60%	22.70%	28.77%	80.20%	0.96	2.56	82.80%	40.50%	44.60%
OWLT	OWLET INC	$135.30M	-567.20%	-15.10%	-15.54%	-43.70%	2.37	1.64	54.80%	-11.20%	-5.38%
OGI	ORGANIGRAM GLOBAL INC	$129.56M	22.00%	14.20%	11.40%	28.60%	0.69	2.61	36.50%	28.00%	26.29%
ANTX	AN2 THERAPEUTICS INC	$135.85M	-53.50%	-48.60%	-47.67%	-106.80%	0.08	14.32	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$2.51B	-35.90%	-33.30%	-23.55%	3,321.70%	0.06	18.83	N/A	N/A	N/A
RANI	RANI THERAPEUTICS HOLDINGS INC	$102.18M	-129.90%	-66.40%	-57.71%	-98.80%	0.33	5.31	100.00%	-618.00%	-594.07%
ALLO	ALLOGENE THERAPEUTICS INC	$445.68M	-50.00%	-36.70%	-31.68%	-44.40%	0.26	10.72	100.00%	-3,566.70%	-3,538.66%
LGND	LIGAND PHARMACEUTICALS INC	$6.05B	20.10%	11.70%	11.41%	15.40%	1.26	31.18	95.40%	67.90%	84.03%
LONA	LEONABIO INC	$60.58M	-411.60%	-225.70%	-288.23%	-1,822.40%	0.69	7.01	N/A	N/A	N/A
TRLV	TRULIEVE CANNABIS CORP	$1.95B	-44.20%	-18.00%	-13.71%	-16.10%	1.71	5.94	59.50%	-41.60%	-23.85%
OKUR	ONKURE THERAPEUTICS INC	$94.96M	-49.00%	-45.80%	-33.99%	4,223.60%	0.04	26.75	N/A	N/A	N/A
NVAX	NOVAVAX INC	$2.11B	N/A	-22.80%	-35.75%	-36.00%	-6.01	2.33	78.60%	-59.90%	-53.99%
HSCS	HEARTSCIENCES INC	$14.83M	-816.20%	-182.00%	498.69%	-1,302.50%	-2.84	0.14	60.90%	-227,024.20%	-209,219.10%
SCTX	SCRIBE THERAPEUTICS INC	$361.97M	N/A	N/A	N/A	N/A	-0.62	0.57	N/A	N/A	N/A
GERN	GERON CORP	$770.97M	-29.30%	-12.30%	-8.33%	-5.80%	1.37	6.92	93.50%	-33.10%	-18.27%
DNA	GINKGO BIOWORKS HOLDINGS INC	$791.92M	-60.20%	-26.90%	-31.77%	-24.20%	1.36	4.57	77.70%	-260.00%	-260.49%
UPC	UNIVERSE PHARMACEUTICALS INC	$2.41M	-3.50%	-2.60%	-2.96%	-6.00%	0.28	4.05	36.50%	-10.90%	-9.65%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$306.05M	-0.90%	-0.90%	0.89%	1.40%	0.03	79.19	N/A	N/A	N/A
NBTX	NANOBIOTIX SA	$1.09B	N/A	-60.90%	-63.66%	-126.50%	-4.84	1.44	100.00%	-459.50%	-234.58%
CRIS	CURIS INC	$1.29M	-1,035.30%	-87.90%	-399.49%	272.40%	3.04	0.49	99.70%	-490.30%	-490.33%
WHWK	WHITEHAWK THERAPEUTICS INC	$172.17M	-53.90%	-50.00%	-43.64%	-80.40%	0.06	17.38	N/A	N/A	N/A
MANE	VERADERMICS INC	$4.86B	N/A	N/A	N/A	N/A	0.02	70.53	N/A	N/A	N/A
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$1.74B	-203.90%	-11.10%	-6.93%	-4.50%	15.29	3.84	70.50%	-15.80%	-8.10%
SNWV	SANUWAVE HEALTH INC	$48.26M	1,728.10%	39.00%	97.60%	89.70%	12.13	1.28	76.30%	32.60%	40.97%
SGRY	SURGERY PARTNERS INC	$1.90B	-5.20%	-1.10%	2.85%	3.60%	2.96	1.95	22.50%	-2.60%	6.34%
POCI	PRECISION OPTICS CORPORATION INC	$50.04M	-23.90%	-13.00%	-14.79%	-42.10%	0.59	2.28	17.20%	-11.50%	-11.03%
AMRN	AMARIN CORP PLC	$244.60M	-6.00%	-4.20%	-5.55%	-7.70%	0.41	3.67	42.00%	-14.60%	-13.71%
MOBI	MOBIA MEDICAL INC	$282.97M	N/A	N/A	N/A	N/A	0.13	13.28	N/A	N/A	N/A
SDGR	SCHRODINGER INC	$1.94B	-16.40%	-8.20%	-11.13%	-14.70%	0.95	2.71	56.90%	-21.00%	-20.05%
RNAC	CARTESIAN THERAPEUTICS INC	$198.78M	N/A	-48.30%	-53.76%	-109.70%	-3.54	7.48	100.00%	-10,422.50%	-10,848.48%
TNDM	TANDEM DIABETES CARE INC	$1.16B	-46.00%	-6.20%	-5.79%	-4.20%	7.85	3.18	56.00%	-6.10%	-5.01%
SOPH	SOPHIA GENETICS SA	$603.56M	-136.70%	-47.40%	-50.03%	-105.30%	1.39	2.69	66.60%	-93.90%	-85.50%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$107.43M	-48.50%	-15.80%	-38.19%	-40.50%	2.63	0.96	83.50%	-34.90%	-33.81%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$260.87M	-37.60%	-30.80%	-36.48%	-30.20%	0.25	10.14	92.10%	-29,747.90%	-29,747.89%
JANX	JANUX THERAPEUTICS INC	$1.05B	-10.80%	-10.10%	-10.83%	-10.80%	0.09	16.35	100.00%	-427.50%	-427.47%
PBM	PSYENCE BIOMEDICAL LTD	$10.43M	-58.60%	-55.80%	-40.88%	-138.50%	0.04	14.62	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$252.48M	-5.80%	-4.90%	-1.72%	-3.90%	0.15	9.25	N/A	N/A	N/A
TDOC	TELADOC HEALTH INC	$1.09B	-13.10%	-6.30%	-11.81%	-18.00%	1.11	0.83	69.00%	-7.10%	-6.53%
CHRS	COHERUS ONCOLOGY INC	$165.32M	-183.40%	-42.90%	-106.38%	-562.00%	2.14	1.77	68.90%	-259.40%	-241.58%
AUTL	AUTOLUS THERAPEUTICS PLC	$431.18M	-178.70%	-49.30%	-56.00%	-33.70%	5.59	4.89	15.70%	-238.70%	-202.47%
BBIO	BRIDGEBIO PHARMA INC	$12.37B	N/A	-61.20%	-197.13%	-31.70%	-1.48	1.23	94.40%	-97.00%	-90.30%
CERT	CERTARA INC	$1.46B	-6.70%	-4.60%	-3.65%	-15.20%	0.45	2.55	61.90%	-16.70%	-11.42%
QTTB	Q32 BIO INC	$239.94M	76.90%	45.20%	30.58%	259.20%	0.09	20.30	100.00%	62.90%	62.87%
PRTA	PROTHENA CORP PUBLIC LTD CO	$429.18M	-15.00%	-13.20%	-15.24%	622.90%	0.06	25.05	100.00%	-80.70%	-81.33%
TGTX	TG THERAPEUTICS INC	$8.32B	72.30%	33.60%	10.14%	10.30%	1.71	4.27	82.40%	55.20%	17.40%
ABUS	ARBUTUS BIOPHARMA CORP	$813.15M	91.00%	82.30%	56.58%	93.20%	0.06	81.42	100.00%	84.20%	84.27%
INO	INOVIO PHARMACEUTICALS INC	$103.19M	-1,005.80%	-111.10%	-711.67%	528.60%	10.30	1.00	N/A	N/A	N/A
BLTE	BELITE BIO INC	$5.97B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
HYPR	HYPERFINE INC	$90.35M	-100.30%	-63.30%	-64.15%	-225.70%	0.71	6.15	51.40%	-210.80%	-207.03%
OVID	OVID THERAPEUTICS INC	$427.70M	-23.60%	-20.50%	-15.54%	-25.60%	0.11	12.39	100.00%	-2,178.90%	-2,178.90%
GH	GUARDANT HEALTH INC	$21.75B	N/A	-25.50%	-28.58%	-21.10%	-9.58	4.03	65.00%	-38.30%	-38.01%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.